Exploring the Evidence of TMS for OCD

The Psychopharmacology Institute is an online platform offering unbiased, practical psychopharmacology updates for healthcare providers, with content updated monthly. It also presents opportunities to earn CME and SA credits.
This video discusses the evidence supporting the use of TMS for OCD, highlighting the FDA-approved devices designed for OCD treatment. It explores the methods and treatment characteristics involved in a study conducted using BrainsWay Deep TMS, unearthing the response rates and partial response rates associated with its application. The video concludes on how to locate the dorsomedial prefrontal cortex, an essential brain region targeted during TMS treatment for OCD.
This is an excerpt from a video lecture. Find the transcript here: psychopharmaco...
If you become a member, you can earn CME credits for this activity. Want to know more? Take a look at the Psychopharmacology Update here: psychopharmaco...
#FDAApprovedTMSTech #BrainsWayDeepTMSResults
#OCDTreatmentInnovation #psychopharmacology